Conor C. Lynch

4.9k total citations
89 papers, 3.7k citations indexed

About

Conor C. Lynch is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Conor C. Lynch has authored 89 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 35 papers in Cancer Research and 31 papers in Molecular Biology. Recurrent topics in Conor C. Lynch's work include Bone health and treatments (28 papers), Protease and Inhibitor Mechanisms (27 papers) and Peptidase Inhibition and Analysis (18 papers). Conor C. Lynch is often cited by papers focused on Bone health and treatments (28 papers), Protease and Inhibitor Mechanisms (27 papers) and Peptidase Inhibition and Analysis (18 papers). Conor C. Lynch collaborates with scholars based in United States, United Kingdom and Ireland. Conor C. Lynch's co-authors include Lynn M. Matrisian, Barbara Fingleton, Gemma Shay, Cathal Walsh, Marilena Tauro, Leah M. Cook, David Basanta, Michelle D. Martin, Jeremy McGuire and Jeremy S. Frieling and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Conor C. Lynch

86 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Conor C. Lynch United States 33 1.5k 1.4k 1.1k 422 416 89 3.7k
József Dudás Austria 37 990 0.7× 1.8k 1.3× 971 0.9× 428 1.0× 418 1.0× 138 4.1k
Yvonne Reiss Germany 25 845 0.6× 2.1k 1.5× 807 0.7× 326 0.8× 1.3k 3.1× 43 4.4k
Mitsuru Furukawa Japan 38 2.2k 1.5× 1.5k 1.1× 1.1k 1.0× 463 1.1× 560 1.3× 344 6.1k
Tzafra Cohen Israel 25 1.4k 0.9× 4.4k 3.2× 1.4k 1.2× 560 1.3× 557 1.3× 40 6.8k
Roberto Tamma Italy 34 971 0.6× 1.8k 1.3× 798 0.7× 483 1.1× 624 1.5× 124 3.8k
Emilio Ciusani Italy 36 1.0k 0.7× 2.1k 1.5× 953 0.8× 348 0.8× 610 1.5× 152 4.7k
Janka Held‐Feindt Germany 41 1.5k 1.0× 1.8k 1.3× 753 0.7× 379 0.9× 1.3k 3.1× 115 4.7k
Patrick Michl Germany 36 2.8k 1.9× 2.3k 1.7× 1.3k 1.1× 554 1.3× 776 1.9× 156 5.9k
Guillem Genové Sweden 27 1.1k 0.7× 3.4k 2.4× 868 0.8× 551 1.3× 712 1.7× 42 7.5k
Hajime Hosoi Japan 35 981 0.7× 3.1k 2.3× 803 0.7× 835 2.0× 406 1.0× 189 5.1k

Countries citing papers authored by Conor C. Lynch

Since Specialization
Citations

This map shows the geographic impact of Conor C. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conor C. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conor C. Lynch more than expected).

Fields of papers citing papers by Conor C. Lynch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conor C. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conor C. Lynch. The network helps show where Conor C. Lynch may publish in the future.

Co-authorship network of co-authors of Conor C. Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Conor C. Lynch. A scholar is included among the top collaborators of Conor C. Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conor C. Lynch. Conor C. Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frieling, Jeremy S., et al.. (2025). PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic Outgrowth. Cancer Research. 86(3). 604–621.
2.
McGuire, Jeremy, et al.. (2024). Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis. Cancer Letters. 606. 217302–217302. 8 indexed citations
3.
Bishop, Ryan T., Tao Li, Praneeth Sudalagunta, et al.. (2024). Acid ceramidase controls proteasome inhibitor resistance and is a novel therapeutic target for the treatment of relapsed / refractory multiple myeloma. Haematologica. 110(6). 1351–1367.
4.
Frieling, Jeremy S., Leticia Tordesillas, María C. Ramello, et al.. (2023). γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer. Science Advances. 9(18). eadf0108–eadf0108. 44 indexed citations
5.
Lo, Chen Hao, Gemma Shay, Jeremy McGuire, et al.. (2021). Host-Derived Matrix Metalloproteinase-13 Activity Promotes Multiple Myeloma–Induced Osteolysis and Reduces Overall Survival. Cancer Research. 81(9). 2415–2428. 13 indexed citations
6.
Lo, Chen Hao, et al.. (2021). Computational modeling reveals a key role for polarized myeloid cells in controlling osteoclast activity during bone injury repair. Scientific Reports. 11(1). 6055–6055. 7 indexed citations
7.
Zhao, Ning, Chen Hao Lo, Meghan A. Rice, et al.. (2019). Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer. Science Translational Medicine. 11(498). 41 indexed citations
8.
Cook, Leah M., Jeremy S. Frieling, Jeremy McGuire, et al.. (2019). Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis. Oncogene. 38(44). 6959–6969. 24 indexed citations
9.
Tauro, Marilena & Conor C. Lynch. (2019). Bone seeking matrix metalloproteinase-2 (MMP-2) inhibitors can prevent bone metastatic breast cancer. Annals of Oncology. 30. iii60–iii61. 3 indexed citations
10.
Roselli, Emiliano, et al.. (2019). CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms. BioDrugs. 33(6). 647–659. 24 indexed citations
11.
Bruinooge, Suanna S., Todd Pickard, Wendy Vogel, et al.. (2018). Understanding the role of advanced practice providers in oncology in the United States. JAAPA. 31(12). 1–12. 8 indexed citations
12.
Tauro, Marilena, Gemma Shay, Antonio Laghezza, et al.. (2017). Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth. Molecular Cancer Therapeutics. 16(3). 494–505. 28 indexed citations
13.
Ember, S.W., Que T. Lambert, Norbert Berndt, et al.. (2017). Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics. Molecular Cancer Therapeutics. 16(6). 1054–1067. 41 indexed citations
14.
Cook, Leah M., et al.. (2014). An Integrated Computational Model of the Bone Microenvironment in Bone-Metastatic Prostate Cancer. Cancer Research. 74(9). 2391–2401. 63 indexed citations
15.
Cook, Leah M., et al.. (2014). Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases. Cancer and Metastasis Reviews. 33(2-3). 511–525. 64 indexed citations
16.
Bruni‐Cardoso, Alexandre, et al.. (2010). Osteoclast-Derived Matrix Metalloproteinase-9 Directly Affects Angiogenesis in the Prostate Tumor–Bone Microenvironment. Molecular Cancer Research. 8(4). 459–470. 56 indexed citations
17.
Bi, Xiaohong, Chetan A. Patil, Conor C. Lynch, et al.. (2010). Raman and mechanical properties correlate at whole bone- and tissue-levels in a genetic mouse model. Journal of Biomechanics. 44(2). 297–303. 76 indexed citations
18.
Thiolloy, Sophie, Jennifer L. Halpern, Ginger E. Holt, et al.. (2009). Osteoclast-Derived Matrix Metalloproteinase-7, but Not Matrix Metalloproteinase-9, Contributes to Tumor-Induced Osteolysis. Cancer Research. 69(16). 6747–6755. 45 indexed citations
19.
Martin, Michelle D., Kathy J. Carter, Mayland Chang, et al.. (2008). Effect of Ablation or Inhibition of Stromal Matrix Metalloproteinase-9 on Lung Metastasis in a Breast Cancer Model Is Dependent on Genetic Background. Cancer Research. 68(15). 6251–6259. 99 indexed citations
20.
Lynch, Conor C., Tracy Vargo-Gogola, Michelle D. Martin, et al.. (2007). Matrix Metalloproteinase 7 Mediates Mammary Epithelial Cell Tumorigenesis through the ErbB4 Receptor. Cancer Research. 67(14). 6760–6767. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by József Dudás Breakdown of academic impact, for papers by Yvonne Reiss Breakdown of academic impact, for papers by Mitsuru Furukawa Breakdown of academic impact, for papers by Tzafra Cohen Breakdown of academic impact, for papers by Roberto Tamma Breakdown of academic impact, for papers by Emilio Ciusani Breakdown of academic impact, for papers by Janka Held‐Feindt Breakdown of academic impact, for papers by Patrick Michl Breakdown of academic impact, for papers by Guillem Genové Breakdown of academic impact, for papers by Hajime Hosoi
Rankless by CCL
2026